誉衡药业：2026年第一次临时股东会决议公告

Core Viewpoint - Yuheng Pharmaceutical announced the approval of several key proposals during its first extraordinary shareholders' meeting of 2026, including amendments to the articles of association and the election of a new independent director [1] Group 1 - The company approved the proposal to amend its articles of association [1] - The election of Xu Yuhong as an independent director for the seventh board of directors was approved [1] - The proposal to repurchase and cancel restricted stocks granted to departing employees, which have not yet been released from restrictions, was also approved [1]